Gurinder Singh

Gurinder Singh is a Senior Scientist at Garuda Therapeutics with experience in utilizing CRISPR/Cas9 for generating hypoimmunogenic iPSC cells for cellular therapy. Previously, Gurinder worked at Morsani College of Medicine, Boston Children's Hospital, Harvard Medical School, and University of Houston in various research roles focused on congenital heart diseases, endothelial dysfunction, atherosclerosis, and diabetes associated cardiac hypertrophy. Gurinder holds a PhD in Biotechnology and Epigenetics from Post Graduate Institute of Medical Education and Research.